Literature DB >> 17065471

Introducing Evangelos S. Gragoudas, the 2006 recipient of the Weisenfeld Award.

Joan W Miller.   

Abstract

Mesh:

Year:  2006        PMID: 17065471     DOI: 10.1167/iovs.06-0693

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


× No keyword cloud information.
  2 in total

1.  [Monotherapy of exudative age-related macular degeneration with ranibizumab in patients at cardiovascular risk. Advantages of ranibizumab compared to a combination with pegaptanib].

Authors:  E Matthé; D Sandner
Journal:  Ophthalmologe       Date:  2011-04       Impact factor: 1.059

2.  [Early treatment of exudative age-related macular degeneration with ranibizumab (Lucentis®): the key to success].

Authors:  E Matthé; D Sandner
Journal:  Ophthalmologe       Date:  2011-03       Impact factor: 1.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.